What is Oral Electrolyte Solution?
Oral electrolyte solutions are consumed widely for rehydration in diarrheal illness and to maintain hydration during exercise. The oral electrolyte solution is composed of calcium, sodium, chloride, and magnesium. Consumption of electrolyte with water is considered to rehydrate your body more quickly and essential for a number of bodily functions. For maintaining hydration during exercise, especially for vigorous high-intensity exercise, the electrolyte solution is recommended.
Global Oral Electrolyte Solutions Market Outlook
The increasing prevalence of diarrhea and awareness about fitness and active lifestyle is propelling the growth of an oral electrolyte solution. American Academy of Pediatrics and WHO recommends using an oral electrolyte solution at the first symptom of illness to prevent dehydration. Solutions of electrolytes, it is preferred when the patient requires electrolyte to restore substantial deficits or continuing losses. By consuming electrolytes in the form of a solution is advantageous for the body's pH levels. To overcome the restraining factor of the market such as lack of awareness about consumption and intake of electrolyte, several measures are carried out to encourage people through a fitness program.
To scale up consumption, includes the participation of a wide range of key players, addressing supply and demand generation together, dedicated efforts are taken to launch and sustain success, including monitoring and evaluation plans to track programs and impacts. Some manufacturer adds a significant amount of minerals along with carbs while some only add a negligible amount for the taste to attract customer.
Global Oral Electrolyte Solutions Market Competitive Landscape
The "Global Oral Electrolyte Solutions Market" study report will provide a valuable insight with an emphasis on global market including some of the major players such Abbott, Mead Johnson, Sanofi, DripDrop Inc., Pendopharm, Johnson & Johnson, Jiangsu Hengrui Medicine, Otsuka Pharmaceutical Factory, Halewood Laboratories Pvt. Ltd., Healthy Life Pharma Private Limited., and Shanghai Trifecta Pharma. Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis.
Customization of the Report
• In case of any queries or customization requirements please connect with our sales team, who will ensure that your requirements are met.
1. INTRODUCTION OF GLOBAL ORAL ELECTROLYTE SOLUTIONS MARKET
1.1. Overview of the Market
1.2. Scope of Report
1.3. Assumptions
2. EXECUTIVE SUMMARY
3. RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1. Data Mining
3.2. Validation
3.3. Primary Interviews
3.4. List of Data Sources
4. GLOBAL ORAL ELECTROLYTE SOLUTIONS MARKET OUTLOOK
4.1. Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Porters Five Force Model
4.4. Value Chain Analysis
5. GLOBAL ORAL ELECTROLYTE SOLUTIONS MARKET, BY TYPE
5.1. Overview
5.2. Lemonadex
5.3. Orange
5.4. Other
6. GLOBAL ORAL ELECTROLYTE SOLUTIONS MARKET, BY APPLICATION
6.1. Overview
6.2. Infants
6.3. Children
6.4. Adults
7. GLOBAL ORAL ELECTROLYTE SOLUTIONS MARKET, BY GEOGRAPHY
7.1. Overview
7.2. North America
7.2.1. U.S.
7.2.2. Canada
7.2.3. Mexico
7.3. Europe
7.3.1. Germany
7.3.2. U.K.
7.3.3. France
7.3.4. Rest of Europe
7.4. Asia Pacific
7.4.1. China
7.4.2. Japan
7.4.3. India
7.4.4. Rest of Asia Pacific
7.5. Rest of the World
8. GLOBAL ORAL ELECTROLYTE SOLUTIONS MARKET COMPETITIVE LANDSCAPE
8.1. Overview
8.2. Company Market Ranking
8.3. Key Development Strategies
9. COMPANY PROFILES
9.1. Abbott
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
9.2. Mead Johnson.
9.2.1. Overview
9.2.2. Financial Performance
9.2.3. Product Outlook
9.2.4. Key Developments
9.3. Sanofi
9.3.1. Overview
9.3.2. Financial Performance
9.3.3. Product Outlook
9.3.4. Key Developments
9.4. DripDrop Inc.
9.4.1. Overview
9.4.2. Financial Performance
9.4.3. Product Outlook
9.4.4. Key Developments
9.5. Johnson & Johnson
9.5.1. Overview
9.5.2. Financial Performance
9.5.3. Product Outlook
9.5.4. Key Developments
9.6. Jiangsu Hengrui Medicine.
9.6.1. Overview
9.6.2. Financial Performance
9.6.3. Product Outlook
9.6.4. Key Developments
9.7. Otsuka Pharmaceutical Factory
9.7.1. Overview
9.7.2. Financial Performance
9.7.3. Product Outlook
9.7.4. Key Developments
9.8. Halewood Laboratories Pvt. Ltd.
9.8.1. Overview
9.8.2. Financial Performance
9.8.3. Product Outlook
9.8.4. Key Developments
9.9. Healthy Life Pharma Private Limited.
9.9.1. Overview
9.9.2. Financial Performance
9.9.3. Product Outlook
9.9.4. Key Developments
9.10. Shanghai Trifecta Pharma
9.10.1. Overview
9.10.2. Financial Performance
9.10.3. Product Outlook
9.10.4. Key Developments
10. Appendix
10.1. Related Reports
Price : US$ 3500 |
Date : Nov 2024 |
Category : Services |
Pages : 142 |
Price : US$ 3500 |
Date : Nov 2024 |
Category : Services |
Pages : 132 |